...
首页> 外文期刊>The Journal of Experomental Medicine >Evidence for the catabolism of polychlorinated biphenyl-induced cytochrome P-448 by microsomal heme oxygenase, and the inhibition of delta-aminolevulinate dehydratase by polychlorinated biphenyls.
【24h】

Evidence for the catabolism of polychlorinated biphenyl-induced cytochrome P-448 by microsomal heme oxygenase, and the inhibition of delta-aminolevulinate dehydratase by polychlorinated biphenyls.

机译:微粒体血红素加氧酶分解多氯联苯诱导的细胞色素P-448的证据,多氯联苯抑制δ-氨基乙酰丙酸酯脱水酶的证据。

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Polychlorinated biphenyls (PCB) are potent inducers of hepatic microsomal CO-binding hemoprotein P-448 (P1-450) and of delta-aminolevulinate synthetase (ALAS) activity. Inorganic cobalt was able to block PCB induction of cytochrome P-448 and to modify the PCB effect on ALAS activity in a time-dependent manner. PCB were also found to decrease the activity of delta-aminolevulinic acid dehydratase (ALAD) in liver. Pretreatment of rats with cobalt (30 min) produced the following changes in PCB actions on heme metabolism in liver: (a) augmentation of the porphyrinogenic effect of PCB, as determined by the total porphyrin content and ALAS activity; (b) augmentation of PCB inhibition of ALAD activity; and (c) blockade of induction of microsomal hemoprotein (cytochrome P-448). PCB did not interfere with cobalt induction of hepatic heme oxygenase activity. The sequence of administration of the metal and the PCB was important in relation to the changes produced in hepatic ALAS activity and microsomal hemoprotein and heme contents. When cobalt was administered 24 h after PCB treatment, the magnitude of induction of ALAS by PCB was lowered, and there was a great reduction in microsomal hemoprotein and heme contents. The renal response to PCB was different than that of the liver. In the kidney, PCB blocked the induction of heme oxygenase and depletion of cellular heme produced by cobalt. Furthermore, renal microsomal heme content was increased by PCB treatment alone or in combination with cobalt. It is concluded that (a) the heme moiety of microsomal cytochrome P-448 is metabolized by the heme oxygenase system, and it is suggested that for this catabolism to take place, the hemoprotein must be first converted to the denatured form of the hemoprotein, cytochrome P-420; (b) that the synthesis of heme in the kidney and the liver are regulated through different mechanisms; and (c) that ionic cobalt controls activity of ALAS by first inhibiting synthesis of the enzyme followed by the indirect induction of the enzyme as a result of the catabolism of heme, the physiological repressor of ALAS, by the metal-induced heme oxygenase. Thus microsomal heme oxygenase may be viewed as having an overall regulatory role in relation to mictochondrial ALAS by virtue of its ability to catabolize endogenous heme.
机译:多氯联苯(PCB)是肝微粒体CO结合血红蛋白P-448(P1-450)和δ-氨基乙酰丙酸合成酶(ALAS)活性的有效诱导剂。无机钴能够以时间依赖的方式阻断PCB对细胞色素P-448的诱导并改变PCB对ALAS活性的影响。还发现PCB可降低肝脏中的δ-氨基乙酰丙酸脱水酶(ALAD)的活性。用钴预处理大鼠(30分钟)后,PCB对肝脏血红素代谢的作用发生了以下变化:(a)通过总卟啉含量和ALAS活性确定PCB的卟啉生成作用增强; (b)增加PCB对ALAD活性的抑制作用; (c)阻断微粒体血蛋白(细胞色素P-448)的诱导。 PCB不会干扰钴诱导肝血红素加氧酶的活性。与肝脏ALAS活性以及微粒体血红蛋白和血红素含量的变化有关,金属和PCB的给药顺序很重要。多氯联苯处理后24小时给予钴治疗后,多氯联苯对ALAS的诱导作用降低,微粒体血红蛋白和血红素含量大大降低。肾脏对PCB的反应不同于肝脏。在肾脏中,PCB阻止了血红素加氧酶的诱导和钴产生的细胞血红素的消耗。此外,单独或与钴联合使用PCB治疗可增加肾微粒体血红素含量。结论是:(a)微粒体细胞色素P-448的血红素部分被血红素加氧酶系统代谢,并且建议为使这种分解代谢发生,必须首先将血红素转化为血红素的变性形式,细胞色素P-420; (b)肾脏和肝脏中血红素的合成是通过不同的机制调节的; (c)离子钴通过首先抑制酶的合成,然后由于金属诱导的血红素加氧酶对血红素(ALAS的生理阻遏物)的分解代谢而间接诱导酶,从而控制了ALAS的活性。因此,由于微粒体血红素加氧酶具有分解代谢内源性血红素的能力,因此被认为相对于线粒体ALAS具有总体调节作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号